Author:
Wang Qi,Xie Wen,Liu Ligai,Wang Peng,Pan Calvin Q.
Funder
Beijing Municipal Center of Hospitals’ Clinical Medicine Development of Special Funding Support
National Natural Science Foundation of China
Beijing Science and Technology Planning Project
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference26 articles.
1. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe;Younossi;Hepatology,2016
2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030;Estes;J Hepatol,2018
3. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013
4. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015
5. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality;YZ;Hepatology,2011
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献